This indicates that COVID-19 patients with a decreased T-cell response, including CD4+ and CD8+ T-cells, are likely to be more vulnerable to disease severity and fatality, highlighting the central role of CD4+ and CD8+ T-cells in SARS-CoV-2 clearance. This evidence concerns the gene CD4 and COVID-19.